Creating a positive family atmosphere
Past News ReleasesRSS
Berkeley, CA (PRWEB) April 26, 2007
Bayer HealthCare Pharmaceuticals announced today that it has launched a new program called Living with Hemophilia to provide practical tips and tools for patients and families living with hemophilia. Nurses at local hemophilia treatment centers around the country are leading interactive discussion groups and the new companion online magazine, LivingWithHemophilia.com, will help continue the discussion by providing articles, expert features, and downloadable forms and checklists.
"Nearly every day, people living with hemophilia are faced with unique challenges," said Terry Tenbrunsel, Vice President, Sales and Marketing. "Bayer HealthCare has created Living with Hemophilia to provide solutions, insight and expert advice in an easy to understand, interactive way." Participants at the local discussion groups and visitors to the online magazine will be encouraged to share their experiences and insights with others.
The new online magazine, LivingWithHemophilia.com, contains four main categories: Essentials, At Home, On the Go and Transitions. Each category includes brief articles, quick tips and checklists for managing life with hemophilia. From "Organizing your treatment supplies" to "Creating a positive family atmosphere," there's something to help everyone. The site also will contain updates from experts, online polls and a special section for health care providers called, "Hemophilia University" which will include continuing education (CE) programming. The first CE module available for registered nurses is called, 'Challenges in Hemophilia: Orthopedic Procedures.'
About Hemophilia A
Hemophilia A, also known as factor VIII deficiency or classic hemophilia, is largely an inherited bleeding disorder in which one of the proteins needed to form blood clots in the body is missing or reduced. Hemophilia A, the most common type of hemophilia, is caused by deficient or defective blood coagulation proteins, known as factor VIII. Hemophilia A is characterized by prolonged or spontaneous bleeding, especially into the muscles, joints, or internal organs. Approximately one in 5,000 males born in the United States has hemophilia.
About Bayer HealthCare LLC
Bayer HealthCare LLC, an affiliate of Bayer HealthCare AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. The Pharmaceuticals division comprises the following business units: Women's Healthcare, Diagnostic Imaging, Specialized Therapeutics, Hematology/Cardiology, Primary Care, and Oncology. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. The products enhance well-being and quality of life by diagnosing, preventing and treating diseases. To learn more about Bayer HealthCare LLC, visit their website: http://www.pharma.bayer.com
This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties, and other factors could lead to material differences between the actual future results, financial situation, development, or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and the U.S. Securities and Exchange Commission (including our Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.